KCNH2 and ventricular fibrillation: They appear to have off-target effects and may be proarrhythmic and increase the risk of ventricular fibrillation.124 Interestingly, some low-affinity KV11.1 blocking agents appear to paradoxically restore IKr by acting as chaperones to transport mutant KV11.1 subunits to the membrane.125